loading page

Managing type 1 diabetes during the COVID-19 pandemic.
  • +8
  • Ines CHARRADA,
  • Cyrine Bennasrallah,
  • Manel Ben Fredj,
  • Nadia Slimene,
  • Wafa Dhouib,
  • Hela Abroug,
  • Imen Zemni,
  • Meriam Oumayma Beji,
  • Chawki Loussaief,
  • Ines Bouanène,
  • Asma Belguith Sriha
Ines CHARRADA
Faculté de medecine de Monastir
Author Profile
Cyrine Bennasrallah
Faculté de medecine de Monastir
Author Profile
Manel Ben Fredj
Faculté de medecine de Monastir
Author Profile
Nadia Slimene
Faculté de medecine de Monastir
Author Profile
Wafa Dhouib
Faculté de medecine de Monastir
Author Profile
Hela Abroug
Faculté de medecine de Monastir
Author Profile
Imen Zemni
Faculté de medecine de Monastir
Author Profile
Meriam Oumayma Beji
Faculté de medecine de Monastir
Author Profile
Chawki Loussaief
Faculté de medecine de Monastir
Author Profile
Ines Bouanène
Faculté de medecine de Monastir
Author Profile
Asma Belguith Sriha
Faculté de medecine de Monastir
Author Profile

Abstract

We report 2 imported cases of COVID 19 in patients with type 1 diabetes. The viral shedding duration was 18 and 22 days in the two cases. Both patients had maintained correct blood glucose levels without ketoacidosis decompensation with regular medical follow-up by telephone.